Effect of primary injection site upon cellular and antitoxin responses to subsequent challenging injection.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000941:Antigens; D000992:Antitoxins; D001202:Ascitic Fluid / Q000276:immunology; D004804:Eosinophils / Q000276:immunology; D005260:Female; D007108:Immune Tolerance; D007249:Inflammation / Q000276:immunology*; D007274:Injections, Intraperitoneal; D051379:Mice; D013745:Tetanus Toxoid
D000941:Antigens; D000992:Antitoxins; D013745:Tetanus Toxoid